In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
400 News Items found
Valerie Rusch, Murray Brennan, Bob Li, Charles Rudin
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discuss Opportunities for Further Collaboration to Accelerate International Clinical Trials During Annual Symposium

Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK)...
Staff involved in implementing the new technology for diagnosing gene mutations in tumors include (from left) Marc Ladanyi, Angela Marchetti, Chris Lau, Laetitia Borsu, and Khedoudja Nafa.
New Technology Will Improve Molecular Testing of Tumors for Patients

Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients' cancers on an individual basis.
Scott Stuart and Dr. Selwyn Vickers stand side by side smiling.
A Message From the Chairman and President

Learn from the MSK President/CEO and Chair of the Board of Trustees about some of the most important advances in cancer care and science at MSK in 2024.
An illustration of lung develop alongside tumor evolution
In the Lab
Shape-Shifting Stem Cells Are Key to Cancer Metastasis and Immune Evasion

By assuming primitive regenerative identities, cancer cells gain the adaptability they need to establish tumors in new parts of the body.
Does Exercise Improve Survival After a Cancer Diagnosis? An Encouraging New Study

Learn how exercise can help many people live longer after they are diagnosed with cancer, according to a new study from MSK's Exercise-Oncology Service.
Cody holds his graduation cap
Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer 

Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.
Lymphoma patient Symantha Wilson
Making Immunotherapy Work for More People

Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.
scale
Q&A
Why Are More Young Adults Getting Cancer? Obesity May Be to Blame

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.
Illustration of a magnifying glass and DNA sequences
Finding
Machine Learning May Help Classify Cancers of Unknown Primary

MSK investigators report a new tool that may help them determine the origin of some metastatic tumors, potentially leading to better targeted treatments.
Physician standing in front of a whiteboard
Finding
Novel Drug Advancing to Phase II Basket Trial of Solid Tumors

Learn more about entrectinib, a targeted therapy being evaluated in patients with solid tumors.